Research group - Joakim Dillner

Our primary research is within Molecular epidemiology, Virology, eScience and Cancer.

Within a center for cervical cancer prevention we perform basic and translational studies on Human Papilloma virus (HPV) and HPV-based prevention, including an international reference laboratory function where we sequence, document and store all new Papilloma viruses. We also run a Nordic center of excellence for better use of IT within health care and research (eScience). We coordinate the EU project HEAP (Human Exposome Assessment Platform) where we develop an AI-driven data platform to evaluate the impact of the internal and external exposome on health. During the Corona pandemic, we mapped the spread of SARS-CoV-2 among healthcare professionals and how vaccination against the virus protects against infection and the spread of infection.

Research group leader Joakim Dillner

H5 Department of Laboratory Medicine

Group members

Jiangrong Wang

Research Specialist
H5 Department of Laboratory Medicine

Research techniques

  • Next Generation Sequencing 
  • HPV-testing and typing 
  • Registry research 
  • eScience
  • Health economy

External funding

The Swedish Research Council, Swedish Cancer Society, Public Health Agency of Sweden, EU, Swedish Foundation for Strategic Research, Bill & Melinda Gates Foundation, Radiumhemmets forskningsfonder, Region Stockholm, Swedish Association of Local Authorities and Regions (SALAR), Knut and Alice Wallenberg foundation, ALF

International Human Papillomavirus Reference Center
Nordic Center of Excellence in Health-Related e-Sciences

HEAP – Human Exposome Assessment Platform

EHEN – European Human Exposome Network

RISCC – Risk-based Screening for Cervical Cancer

Selected publications

Antibodies to SARS-CoV-2 and risk of past or future sick leave.
Dillner J, Elfström KM, Blomqvist J, Eklund C, Lagheden C, Nordqvist-Kleppe S, Hellström C, Olofsson J, Andersson E, Jernbom Falk A, Bergström S, Hultin E, Pin E, Månberg A, Nilsson P, Hedhammar M, Hober S, Mattsson J, Mühr LSA, Conneryd Lundgren K
Sci Rep 2021 03;11(1):5160

Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer.
Hortlund M, van Mol T, Van de Pol F, Bogers J, Dillner J
Int J Cancer 2021 Feb;():

High amounts of SARS-CoV-2 precede sickness among asymptomatic healthcare workers.
Dillner J, Elfström KM, Blomqvist J, Engstrand L, Uhlén M, Eklund C, Boulund F, Lagheden C, Hamsten M, Nordqvist-Kleppe S, Seifert M, Hellström C, Olofsson J, Andersson E, Falk AJ, Bergström S, Hultin E, Pin E, Pimenoff VN, Hassan S, Månberg A, Nilsson P, Hedhammar M, Hober S, Mattsson J, Mühr LSA, Lundgren KC
J Infect Dis 2021 Feb;():

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs.
Vänskä S, Luostarinen T, Lagheden C, Eklund C, Kleppe SN, Andrae B, Sparén P, Sundström K, Lehtinen M, Dillner J
Am J Epidemiol 2021 04;190(4):506-514

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR.
Arroyo Mühr LS, Lagheden C, Lei J, Eklund C, Nordqvist Kleppe S, Sparén P, Sundström K, Dillner J. Br J Cancer 2020 12;123(12):1790-1795